These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Thinking outside the (black) box: a new research agenda. Seligman PJ Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):387-9. PubMed ID: 16739245 [No Abstract] [Full Text] [Related]
4. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
5. Communicating the risks of medicines: time to move forward. Dal Pan GJ Med Care; 2012 Jun; 50(6):463-5. PubMed ID: 22581011 [No Abstract] [Full Text] [Related]
6. Drug shortages in America: what about the gastroenterologist? Menees SB; Vargo JJ; Bonta C; Mayo L; Jacobson BC Gastrointest Endosc; 2013 Apr; 77(4):641-5. PubMed ID: 23498144 [No Abstract] [Full Text] [Related]
7. The pharmaceutical industry: angels or demons? Kirsch M Am J Gastroenterol; 2010 Dec; 105(12):2530-2. PubMed ID: 21131923 [No Abstract] [Full Text] [Related]
9. Off-label pharmaceutical use: balancing information, risks, and benefits. Kozma CM Manag Care Interface; 2004 Jan; 17(1):29-30. PubMed ID: 15035597 [No Abstract] [Full Text] [Related]
10. Will compounding exist in the 21st century? Lynn RC J Am Vet Med Assoc; 1994 Jul; 205(2):296-7. PubMed ID: 7928606 [No Abstract] [Full Text] [Related]
11. Another pithy editorial. Czap A Altern Med Rev; 2011 Jun; 16(2):103-5. PubMed ID: 21770089 [No Abstract] [Full Text] [Related]
12. The changing landscape of pharmaceutical medicine. Lazarus A Physician Exec; 2004; 30(4):40-3. PubMed ID: 15344644 [No Abstract] [Full Text] [Related]
13. Distinguishing product and practice regulation in personalized medicine. Evans BJ Clin Pharmacol Ther; 2007 Feb; 81(2):288-93. PubMed ID: 17259953 [TBL] [Abstract][Full Text] [Related]
14. New recommendations to modernize drug manufacturing. FDA Consum; 2007; 41(1):4. PubMed ID: 17354283 [No Abstract] [Full Text] [Related]
15. Dispensing drugs for profit. Siepel T N Y State J Med; 1988 Aug; 88(8):442. PubMed ID: 3173834 [No Abstract] [Full Text] [Related]
16. Protecting consumers from counterfeit drugs. FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838 [No Abstract] [Full Text] [Related]
17. Use of microbiology in drug monitoring. Kirshbaum A Bull Parenter Drug Assoc; 1971; 25(5):226-32. PubMed ID: 5109889 [No Abstract] [Full Text] [Related]
18. ACOG Committee Opinion. Routine human immunodeficiency virus screening. American College of Obstetricians and Gynecologists Obstet Gynecol; 2008 Aug; 112(2 Pt 1):401-3. PubMed ID: 18669743 [No Abstract] [Full Text] [Related]
19. Compounding pharmacies: a viable option, or merely a liability? O'Brien D; Cohen I; Kennedy DJ PM R; 2013 Nov; 5(11):974-81. PubMed ID: 24247017 [No Abstract] [Full Text] [Related]
20. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related] [Next] [New Search]